Damora Therapeutics, Inc. (DMRA): SCHEDULE 13G filed Jan 12, 2026

Form type

SCHEDULE 13G

Filing date

Jan 12, 2026

Accession number

0001193125-26-010366

Filer

Damora Therapeutics, Inc. (CIK 1800315)